Skip to content
Arvee Laboratories logo

Arvee Laboratories (India)

ARVEE NSE
₹216.03 +2.23 (+1.04%)
P/E
58.86
View as Markdown
MCP
Close 4 Nov 2026 ₹216.03 +56.96 +35.8% 1Y
Start ₹159.07

Key Fundamentals

MicrocapChemicals & PetrochemicalsChemicals

Price-based figures as of · EPS basis: Standalone · TTM

ROCE
7.53%
Debt to Equity
0.03
EPS (TTM)
₹3.67
Book Value
₹30.66
Market Cap
—
P/E (TTM)
58.86
P/B
7.05
ROE
7.32%
Dividend Yield
0.00%
EBITDA
₹3.90 Cr
52W High
₹290.78
52W Low
₹129.11
Day Range
₹207.30 – ₹224.49
Volume
4,827

Peer Comparison

Commodities › Chemicals › Specialty Chemicals

Arvee Laboratories peer comparison
Pidilite Industries
₹1,510.2058.04₹1,54,107 Cr13.721.42%23.90%31.00%₹15,399 Cr₹2,677 Cr
Gujarat Fluorochemicals
₹4,613.3083.76₹49,073 Cr6.040.07%7.82%9.64%₹5,303 Cr₹600 Cr
Navin Fluorine International
₹8,785.0057.03₹44,060 Cr10.100.09%19.60%21.00%₹3,634 Cr₹789 Cr
Deepak Nitrite
₹1,578.4027.48₹20,919 Cr3.320.49%9.82%11.40%₹8,575 Cr₹784 Cr
Aether Industries
₹1,540.7086.90₹20,030 Cr7.880.00%9.66%11.90%₹1,231 Cr₹235 Cr
Aarti Industries
₹447.5530.57₹15,838 Cr2.590.23%7.13%6.86%₹9,010 Cr₹531 Cr
Atul
₹5,156.5019.67₹14,827 Cr2.310.59%11.50%14.90%₹6,969 Cr₹788 Cr
Arvee Laboratories (this company)
₹216.0358.86₹241 Cr7.050.00%7.32%7.53%₹41 Cr₹4 Cr
Median 8 companies₹1,559.5557.54₹20,474 Cr6.550.16%9.74%11.65%₹6,136 Cr₹692 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

47 Average

Data confidence 100/100

surveillance:ASM1

Category scores

Quality
53
Average
Returns, margins, earnings quality 22% weight
Valuation
24
Poor
Cheap vs sector & own history 24% weight
Growth
58
Good
Sales & profit trajectory 9% weight
Financial Health
90
Strong
Solvency, leverage, coverage 9% weight
Momentum
92
Strong
Trend strength, vol-adjusted 12% weight
Ownership
50
Average
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

2
  • Company is almost debt free.
  • Company is expected to give good quarter

Weaknesses

6
  • Stock is trading at 7.38 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of -7.83% over past five years.
  • Tax rate seems low
  • Company has a low return on equity of 5.88% over last 3 years.
  • Debtor days have increased from 91.4 to 121 days.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bullish2611
OscillatorsBearish261
Moving AveragesStrong Bullish0010

Key readings

RSI (14)
56.64
Neutral
MACD (12,26,9)
1.43
Bullish
SMA (50)
196.98
Bullish
SMA (200)
169.73
Bullish

As of

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
10Y+1.62%
5Y−7.83%
3Y−19.92%
1Y−18.13%
TTM+16.65%

Net profit

Net profit growth by window
10Y+29.55%
5Y−1.15%
3Y−15.00%
1Y+17.67%
TTM+195.62%

Operating cash flow

Operating cash flow growth by window
10Y—
5YTurned negative
3YTurned negative
1YOutflow narrowed by ₹0.09 Cr
TTM—

10Y: The statements do not go back far enough for this window.

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10Y−8.52 pp
5Y−2.72 pp
3Y−1.79 pp
1Y+0.71 pp
TTM+6.15 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹34.44 Cr
Mar 2018₹47.78 Cr
Mar 2019₹54.90 Cr
Mar 2020₹45.42 Cr
Mar 2021₹47.38 Cr
Mar 2022₹40.33 Cr
Mar 2023₹61.35 Cr
Mar 2024₹30.35 Cr
Mar 2025₹38.49 Cr
Mar 2026₹31.51 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹1.55 Cr
Mar 2018₹1.09 Cr
Mar 2019₹2.26 Cr
Mar 2020₹2.30 Cr
Mar 2021₹2.68 Cr
Mar 2022₹2.57 Cr
Mar 2023₹4.12 Cr
Mar 2024₹1.05 Cr
Mar 2025₹2.15 Cr
Mar 2026₹2.53 Cr

Quarterly Results

₹ Cr
ARVEE quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales
7.6
8.91
7.7
6.14
10.6
12.53
8.91
6.45
7.48
3.45
9.78
10.8
17.23
24.93
Expenses
6.62
8.22
7.17
5.35
9.06
11.03
8.57
6.23
7.14
3.33
8.15
9.7
14.74
21.5
Operating Profit
0.98
0.69
0.53
0.79
1.54
1.5
0.34
0.22
0.34
0.12
1.63
1.1
2.49
3.43
OPM %
12.89%
7.74%
6.88%
12.87%
14.53%
11.97%
3.82%
3.41%
4.55%
3.48%
16.67%
10.19%
14.45%
13.76%
Other Income
0.09
0.09
0.19
0.21
0.11
0.16
0.19
0.21
0.17
0.23
0.14
0.15
0.18
0.34
Interest
0.07
0.08
0.05
0.05
0.08
0.05
0.05
0.07
0.04
0.04
0.07
0.08
0.06
0.1
Depreciation
0.35
0.42
0.35
0.37
0.31
0.3
0.28
0.27
0.29
0.3
0.3
0.31
0.32
0.33
PBT
0.65
0.28
0.32
0.58
1.26
1.31
0.2
0.09
0.18
0.01
1.4
0.85
2.29
3.34
Tax %
24.62%
25%
25%
81.03%
25.4%
25.19%
25%
22.22%
5.56%
0%
−30.71%
38.37%
26.2%
23.65%
Net Profit
0.49
0.21
0.24
0.12
0.94
0.98
0.15
0.07
0.17
0.01
1.83
0.52
1.69
2.56
EPS (₹)
0.44
0.19
0.22
0.11
0.85
0.89
0.14
0.06
0.15
0.01
1.66
0.47
1.53
—

Sep 2026: from the results filed on 3 Nov 2026, ahead of the full statement, so some rows are blank.

Profit & Loss

₹ Cr
ARVEE profit and loss, annual, ₹ crore
Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
26.82
34.44
47.78
54.9
45.42
47.38
40.33
61.35
30.35
38.49
31.51
41.26
Expenses
21.83
28.54
40.61
48.73
39.4
41.31
34.65
54.06
27.41
34.88
28.33
35.92
Operating Profit
4.99
5.9
7.17
6.17
6.02
6.07
5.68
7.29
2.94
3.61
3.18
5.34
OPM %
18.61%
17.13%
15.01%
11.24%
13.25%
12.81%
14.08%
11.88%
9.69%
9.38%
10.09%
12.94%
Other Income
0.1
0.51
0.23
0.35
0.35
0.56
0.46
1.35
0.64
0.66
0.68
0.7
Interest
3.07
3.48
3.33
1.63
0.99
0.58
0.37
0.39
0.25
0.25
0.23
0.25
Depreciation
1.49
2.07
2.15
2.35
2.29
2.41
2.32
2.08
1.5
1.15
1.21
1.23
PBT
0.53
0.86
1.92
2.54
3.09
3.64
3.45
6.17
1.83
2.87
2.43
4.56
Tax %
66.04%
−81.4%
43.23%
11.02%
25.89%
26.37%
25.51%
33.23%
42.62%
25.09%
−3.7%
—
Net Profit
0.19
1.55
1.09
2.26
2.3
2.68
2.57
4.12
1.05
2.15
2.53
4.05
EPS (₹)
0.23
1.91
0.99
2.05
2.09
2.43
2.33
3.74
0.95
1.95
2.3
3.67
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—

Balance Sheet

₹ Cr
ARVEE balance sheet, annual, ₹ crore
Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
4.05
4.05
5.51
5.51
5.51
11.02
11.02
11.02
11.02
11.02
11.02
Reserves
−1.41
0.15
8.69
10.95
13.25
10.42
12.92
17.04
18.09
20.24
22.77
Borrowings
25.32
24.99
16.15
12.87
3.87
8.88
3.13
1
1
1.03
1.11
Other Liabilities
7.25
6.49
13.77
7.81
11
10.73
11.61
9.63
8.45
5.29
7.99
Total Liabilities
35.21
35.68
44.12
37.14
33.63
41.05
38.68
38.69
38.56
37.58
42.89
Fixed Assets
13.15
16.88
14.88
12.65
13.18
13.81
13.84
12.68
12.67
15.27
16.72
CWIP
4.3
0
1.18
2.32
1.78
0.97
0.98
1.53
2.62
0.73
0.9
Investments
0
0
0
1.95
3.09
2.03
0
0
0
0
1.7
Other Assets
17.76
18.8
28.06
20.22
15.58
24.24
23.86
24.48
23.27
21.58
23.57
Total Assets
35.21
35.68
44.12
37.14
33.63
41.05
38.68
38.69
38.56
37.58
42.89

Cash Flow

₹ Cr
ARVEE cash flow, annual, ₹ crore
Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
—
4.03
6.02
9.46
10.31
1.71
0.68
2.93
3.66
−0.21
−0.12
Investing
—
−1.4
−1.23
−2.85
−3.08
−0.6
0.06
−1.26
−2.16
−1.32
0.5
Financing
—
−2.92
−3.78
−4.92
−9.9
4.52
−6.06
−2.42
−0.19
−0.12
−0.16
Net Cash Flow
—
−0.29
1
1.68
−2.67
5.63
−5.32
−0.75
1.31
−1.64
0.23
Free Cash Flow
—
2.54
4.68
7.96
8.02
−0.53
−1.68
1.47
1.07
−2.06
−2.95
CFO/EBITDA
—
57
96
158
184
44
29
64
139
10
3

Ratios

ARVEE financial ratios, annual
Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
82.61
87.12
118
52.66
52.4
60.7
110
72.94
73.48
79.66
121
Inventory Days
155
105
99.61
42.9
80.96
91.96
93.24
42.29
159
80.31
229
Days Payable
131
98.14
150
55.84
126
118
160
73.3
164
57.72
159
Cash Conversion Cycle
107
93.5
67.84
39.72
7.72
34.59
42.9
41.94
68.01
102
191
Working Capital Days
30.08
30.84
30.79
−6.52
10.29
−10.63
49.96
70.44
95.97
104
168
ROCE %
—
15.19%
17.64%
13.67%
14.9%
14.92%
12.89%
23.34%
6.83%
9.58%
7.53%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Arvee Laboratories insights

56 extracted metrics across FY16–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 73.50%
  • Public 26.24%
  • Others 0.26%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Documents

Frequently Asked Questions about Arvee Laboratories (India)

What does Arvee Laboratories (India) Ltd do?
Incorporated in 2012, Arvee Laboratories India Ltd manufactures specialized chemicals
Where is Arvee Laboratories (India) Ltd (ARVEE) listed?
Arvee Laboratories (India) Ltd trades as ARVEE on the NSE.
Which sector does Arvee Laboratories (India) Ltd belong to?
Arvee Laboratories (India) Ltd is classified under the Chemicals sector, in the Specialty Chemicals industry.
What is the PE ratio of Arvee Laboratories (India) Ltd?
Arvee Laboratories (India) Ltd trades at a PE ratio of 58.86 as of 4 Nov 2026, on earnings per share of ₹3.67, against a book value of ₹30.66 per share.
What is the 52-week high and low of Arvee Laboratories (India) Ltd?
Over the last 52 weeks Arvee Laboratories (India) Ltd has traded between ₹129.11 and ₹290.78 as of 4 Nov 2026.
What is the Return on Equity (ROE) of Arvee Laboratories (India) Ltd?
Arvee Laboratories (India) Ltd reported a return on equity of 7.32%. Its debt-to-equity ratio is 0.03.

Company Information

Incorporated in 2012, Arvee Laboratories India Ltd manufactures specialized chemicals

Website arveelabs.com
CEO Mr. Shalin Sudhakarbhai Patel
Employees 70
Listed 22 Mar 2021
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/ARVEE.md for Arvee Laboratories (India) Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Chemical & Petrochemical stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month